PFENNIGER RICHARD C JR 4
4 · GeneDx Holdings Corp. · Filed Jun 23, 2026
Research Summary
AI-generated summary of this filing
GeneDx (WGS) Director Richard Pfenniger Receives RSUs, Exercises 3,576
What Happened
Richard C. Pfenniger Jr., a director of GeneDx Holdings Corp. (WGS), was awarded 4,248 restricted stock units (RSUs) and, on the same date (2026-06-18), converted/exercised 3,576 derivative units into shares. All reported transactions show $0.00 per share. The filing also reports a simultaneous disposal of the 3,576 shares obtained through conversion; the filing lists no cash consideration for that disposition.
Key Details
- Transaction date: 2026-06-18. Filing date: 2026-06-23 (appears to be after the usual two-business-day Form 4 window).
- Transactions reported: A = grant of 4,248 RSUs (award); M = exercise/conversion of 3,576 derivatives (acquired) and M = conversion/transfer of 3,576 shares (disposed). All at $0.00.
- Shares owned after the transactions: Not specified in the filing.
- Footnotes of note:
- F1: Each RSU represents a contingent right to receive 1 share upon settlement for no consideration.
- F2: The newly granted 4,248 RSUs vest on the earlier of the 2027 annual meeting or the first anniversary of the grant, subject to continued service; they have no expiration date.
- F3: The converted/vested award (the 3,576 units) vested on the earlier of the 2026 annual meeting or first anniversary, subject to continued service.
- The filing does not specify the reason for the $0.00 disposal (e.g., sale, tax withholding, or transfer).
Context
RSU awards (A) are grants that convert into shares upon vesting and do not require cash outlay by the grantee; they are commonly used as compensation. The reported exercise/conversion (M) with an immediate disposal means Pfenniger did not retain an increased share position from those 3,576 units — but the filing does not explain the mechanics of the disposal. This filing documents compensation and a conversion event rather than an outright market purchase or cash sale for proceeds.
Insider Transaction Report
- Exercise/Conversion
Class A Common Stock
[F1]2026-06-18+3,576→ 45,082 total - Award
Restricted Stock Unit
[F1][F2]2026-06-18+4,248→ 4,248 total→ Class A Common Stock (4,248 underlying) - Exercise/Conversion
Restricted Stock Unit
[F1][F3]2026-06-18−3,576→ 0 total→ Class A Common Stock (3,576 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- [F2]The entire award shall vest on the earlier of the (i) date of the 2027 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.
- [F3]The entire award vested or vests on the earlier of the: (i) date of the 2026 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.